Scientific Presentations
Quality of Retinal Images Captured by a Self-Operated, Home-Based OCT System
Anat Loewenstein, MD
Performance of a Novel Deep Learning Algorithm for Automatic Retinal Fluid Quantification in Home OCT Images
Judy Kim, MD
Artificial Intelligence Algorithm May Improve Performance of Retinal Specialists in Detection of Retinal Fluid on OCT in AMD: AREDS2 10-Year Study
Michael Elman, MD
A Novel AI-Based System for Identifying, quantifying and visualizing fluid on OCT scans in retinal pathologies
Anat Loewenstein, MDSCANLY Home OCT FDA Intended Use
SCANLY Home OCT has not been approved by FDA for use other than described in the following Intend Use: The Notal Vision Home Optical Coherence Tomography (OCT) System is an Artificial Intelligence (AI)-based Home Use device indicated for visualization of intraretinal and subretinal hypo-reflective spaces in a 10 by 10-degrees area centered on the point of fixation of eyes diagnosed with neovascular age-related macular degeneration (NV-AMD). In addition, it provides segmentation and an estimation of the volume of hypo-reflective spaces. The Notal Home OCT device is intended for imaging at home between regularly scheduled clinic assessments and not intended to be used to make treatment decisions or replace standard-of care regularly scheduled examinations and clinical testing as needed, including in-office imaging and assessments for changes in vision, by an ophthalmologist.
See also Warnings and Precautions.
ForeseeHome FDA Intended Use
ForeseeHome has not been approved by FDA for use other than described in the following Indication for Use: The ForeseeHome is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration as an aid in monitoring progression of disease factors causing metamorphopsia including, but not limited to choroidal neovascularization (CNV). It is intended to be used at home for patients with stable fixation.
